Clinical Trial Update: Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating AHCC (Active Hexose Correlated Compound) supplementation to prevent respiratory tract infections in children aged 2-4; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• AHCC (Active Hexose Correlated Compound)

Snippet

Sponsor: Hasanuddin University | Conditions: Respiratory Tract Infections (RTI) | Phase 4 | Status: NOT_YET_RECRUITING